Dr Ailawadhi on the Potential Sequencing of Bispecific Antibodies in Multiple Myeloma

Sikander Ailawadhi, MD, discusses key considerations for the potential sequencing of bispecific antibodies and other BCMA-directed therapies in multiple myeloma.

Related Keywords

,Sikander Ailawadhi ,Car Therapy Program ,Department Of Hematology ,Cell Therapy Program ,Mayo Clinic ,Myeloma ,Bispecific Antibodies ,Bcma Directed Therapies In Multiple Myeloma ,